A detailed history of Commonwealth Equity Services, LLC transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 26,080 shares of IMMX stock, worth $42,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,080
Previous 26,080 -0.0%
Holding current value
$42,249
Previous $52,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$2.64 - $6.68 $5,860 - $14,829
-2,220 Reduced 7.84%
26,080 $80,000
Q4 2023

Feb 06, 2024

SELL
$2.82 - $7.27 $1,565 - $4,034
-555 Reduced 1.92%
28,300 $196,000
Q3 2023

Oct 23, 2023

BUY
$1.63 - $3.68 $9,828 - $22,190
6,030 Added 26.42%
28,855 $99,000
Q2 2023

Aug 10, 2023

BUY
$1.6 - $2.9 $36,520 - $66,192
22,825 New
22,825 $61,000

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $22.5M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.